<?xml version="1.0" encoding="us-ascii"?>
<!-- EDGAR Online I-Metrix Xcelerate Risk Return XBRL Instance Document, based on XBRL 2.1  http://www.edgar-online.com/ -->
<!-- Created (UTC): 12/20/2012 4:13:54 PM -->
<!-- XBRL File Set ID: 94060f6a-8eaa-47d3-ac82-bf155260faea -->
<!-- App Version: 3.0.0.183, 6.1.7601.65536, 14.0 -->
<!-- Copyright (c) 2005-2012 EDGAR Online, Inc. All Rights Reserved. -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/2008/inlineXBRL/transformation" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:rr="http://xbrl.sec.gov/rr/2010-02-28" xmlns:dei="http://xbrl.us/dei/2009-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ck0001027596="http://www.tebergfund.com/20121219">
  <link:schemaRef xlink:href="ck0001027596-20121219.xsd" xlink:type="simple" />
  <unit id="USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="Ratio">
    <measure>pure</measure>
  </unit>
  <context id="DocumentContext" xmlns="http://www.xbrl.org/2003/instance">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001027596</identifier>
    </entity>
    <period>
      <startDate>2012-12-19</startDate>
      <endDate>2012-12-19</endDate>
    </period>
  </context>
  <context id="S000005071member_C000013857member" xmlns="http://www.xbrl.org/2003/instance">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001027596</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">ck0001027596:S000005071Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="rr:ProspectusShareClassAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">ck0001027596:C000013857Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-12-19</startDate>
      <endDate>2012-12-19</endDate>
    </period>
  </context>
  <context id="CTXT_P0001S000005071member_S000005071member" xmlns="http://www.xbrl.org/2003/instance">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001027596</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:DocumentInformationDocumentAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">ck0001027596:P0001-S000005071Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">ck0001027596:S000005071Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-12-19</startDate>
      <endDate>2012-12-19</endDate>
    </period>
  </context>
  <dei:DocumentType contextRef="DocumentContext">Other</dei:DocumentType>
  <dei:DocumentPeriodEndDate contextRef="DocumentContext">2012-12-19</dei:DocumentPeriodEndDate>
  <dei:EntityRegistrantName contextRef="DocumentContext">ADVISORS SERIES TRUST</dei:EntityRegistrantName>
  <dei:EntityCentralIndexKey contextRef="DocumentContext">0001027596</dei:EntityCentralIndexKey>
  <dei:AmendmentFlag contextRef="DocumentContext">false</dei:AmendmentFlag>
  <dei:DocumentCreationDate contextRef="DocumentContext">2012-12-19</dei:DocumentCreationDate>
  <dei:DocumentEffectiveDate contextRef="DocumentContext">2012-12-19</dei:DocumentEffectiveDate>
  <rr:ProspectusDate contextRef="DocumentContext">2012-07-29</rr:ProspectusDate>
  <rr:RiskReturnHeading contextRef="CTXT_P0001S000005071member_S000005071member">THE TEBERG FUND  &amp;nbsp;</rr:RiskReturnHeading>
  <ck0001027596:SupplementTextBlock contextRef="CTXT_P0001S000005071member_S000005071member">&lt;p class="MsoNormal" align="right" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt; text-align:right;line-height:normal;text-autospace:none"&gt;&lt;b&gt;&lt;font style=&apos;font-size:10.0pt;font-family:"Times New Roman","serif"&apos;&gt;December 19, 2012&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:12.0pt;font-family:"Times New Roman","serif"&apos;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" align="center" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt; text-align:center;line-height:normal;text-autospace:none"&gt;&lt;b&gt;&lt;font style=&apos;font-size:10.0pt;font-family:"Times New Roman","serif"&apos;&gt;THE TEBERG FUND&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt;text-align: justify;line-height:normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:10.0pt; font-family:"Times New Roman","serif"&apos;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" align="center" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt; text-align:center;line-height:normal;text-autospace:none"&gt;&lt;b&gt;&lt;font style=&apos;font-size:10.0pt;font-family:"Times New Roman","serif"&apos;&gt;A series of Advisors Series Trust (the &#8220;Trust&#8221;)&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:12.0pt;font-family:"Times New Roman","serif"&apos;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt;text-align: justify;line-height:normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:10.0pt; font-family:"Times New Roman","serif"&apos;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" align="center" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt; text-align:center;line-height:normal;text-autospace:none"&gt;&lt;b&gt;&lt;font style=&apos;font-size:10.0pt;font-family:"Times New Roman","serif"&apos;&gt;Supplement to the Prospectus&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;  &lt;p class="MsoNormal" align="center" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt; text-align:center;line-height:normal;text-autospace:none"&gt;&lt;b&gt;&lt;font style=&apos;font-size:10.0pt;font-family:"Times New Roman","serif"&apos;&gt;and Statement of Additional Information (&#8220;SAI&#8221;)&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;  &lt;p class="MsoNormal" align="center" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt; text-align:center;line-height:normal;text-autospace:none"&gt;&lt;b&gt;&lt;font style=&apos;font-size:10.0pt;font-family:"Times New Roman","serif"&apos;&gt;Dated July 29, 2012&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;  &lt;p class="MsoNormal" align="center" style="font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-top:8.5pt;margin-right:0in; margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:center; line-height:1.5pt;background:black;text-autospace:none"&gt;&lt;font style=&apos;font-size: 12.0pt;font-family:"Times New Roman","serif"&apos;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-top:8.5pt;margin-right:0in;margin-bottom:0in; margin-left:0in;margin-bottom:.0001pt;line-height:normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:12.0pt;font-family:"Times New Roman","serif"&apos;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt;text-align: justify;line-height:normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:10.0pt; font-family:Symbol&apos;&gt;&#183; &amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;font style=&apos;font-size:10.0pt; font-family:"Times New Roman","serif"&apos;&gt; Effective December 20, 2012, the Fund&#8217;s expense cap on net annual fund operating expenses will be reduced from 2.50% to 1.75% of the Fund&#8217;s average daily net assets, excluding acquired fund fees and expenses, interest, taxes and extraordinary expenses.&amp;nbsp;&amp;nbsp;This contractual reduction will be in effect for a minimum term of one year and any future increase requires the prior approval of the Trust&#8217;s Board of Trustees and notice to shareholders.&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:12.0pt;font-family:"Times New Roman","serif"&apos;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt;text-align: justify;line-height:normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:10.0pt; font-family:"Times New Roman","serif"&apos;&gt;In connection with this reduction, the &#8220;Fees and Expenses of the Fund&#8221; section on page 1 of the Prospectus is hereby deleted and replaced with the following:&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;margin-bottom:10.0pt;line-height:115%;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;"&gt;&amp;nbsp;&lt;/p&gt;</ck0001027596:SupplementTextBlock>
  <rr:PortfolioTurnoverRate contextRef="CTXT_P0001S000005071member_S000005071member" unitRef="Ratio" decimals="4">2.2414</rr:PortfolioTurnoverRate>
  <rr:ExpenseHeading contextRef="CTXT_P0001S000005071member_S000005071member">Fees and Expenses of the Fund  &amp;nbsp;</rr:ExpenseHeading>
  <rr:ExpenseNarrativeTextBlock contextRef="CTXT_P0001S000005071member_S000005071member">&lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt;text-align: justify;line-height:normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:10.0pt; font-family:"Times New Roman","serif"&apos;&gt;This table describes the fees and expenses that you may pay if you buy and hold shares of the Fund.&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;margin-bottom:10.0pt;line-height:115%;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;"&gt;&amp;nbsp;&lt;/p&gt;</rr:ExpenseNarrativeTextBlock>
  <rr:ShareholderFeesCaption contextRef="CTXT_P0001S000005071member_S000005071member">SHAREHOLDER FEES  (fees paid directly from your investment)  &amp;nbsp;</rr:ShareholderFeesCaption>
  <rr:OperatingExpensesCaption contextRef="CTXT_P0001S000005071member_S000005071member">ANNUAL FUND OPERATING EXPENSES  (expenses that you pay each year as a percentage of the value of your investment)  &amp;nbsp;</rr:OperatingExpensesCaption>
  <rr:ExpenseExampleHeading contextRef="CTXT_P0001S000005071member_S000005071member">Example.&amp;nbsp;&amp;nbsp;</rr:ExpenseExampleHeading>
  <rr:ExpenseExampleNarrativeTextBlock contextRef="CTXT_P0001S000005071member_S000005071member">&lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;margin-bottom:10.0pt;line-height:115%;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;"&gt;&lt;font style=&apos;font-size:10.0pt;line-height:115%;font-family: "Times New Roman","serif"&apos;&gt;This Example is intended to help you compare the cost of investing in the Fund with the cost of investing in other mutual funds.&amp;nbsp;&amp;nbsp;The Example assumes that you invest $10,000 in the Fund for the time periods indicated and then redeem all of your shares at the end of those periods.&amp;nbsp;&amp;nbsp;The Example also assumes that your investment has a 5% return each year and that the Fund&#8217;s operating expenses remain the same.&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;</rr:ExpenseExampleNarrativeTextBlock>
  <rr:ExpenseExampleByYearCaption contextRef="CTXT_P0001S000005071member_S000005071member">Although your actual costs may be higher or lower, based on these assumptions your costs would be:</rr:ExpenseExampleByYearCaption>
  <rr:PortfolioTurnoverHeading contextRef="CTXT_P0001S000005071member_S000005071member">Portfolio Turnover.</rr:PortfolioTurnoverHeading>
  <rr:PortfolioTurnoverTextBlock contextRef="CTXT_P0001S000005071member_S000005071member">&lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;margin-bottom:10.0pt;line-height:115%;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;"&gt;&lt;font style=&apos;font-size:10.0pt;line-height:115%;font-family: "Times New Roman","serif"&apos;&gt;The Fund pays transaction costs when it buys and sells securities (or &#8220;turns over&#8221; its portfolio).&amp;nbsp;&amp;nbsp;A higher portfolio turnover rate may indicate higher transaction costs and may result in higher taxes when Fund shares are held in a taxable account.&amp;nbsp;&amp;nbsp;These costs, which are not reflected in Annual Fund Operating Expenses or in the Example, affect the Fund&#8217;s performance.&amp;nbsp;&amp;nbsp;During the most recent fiscal year, the Fund&#8217;s portfolio turnover rate was 224.14% of the average value of its portfolio.&lt;/font&gt;&lt;/p&gt;</rr:PortfolioTurnoverTextBlock>
  <ck0001027596:SupplementClosingTextBlock contextRef="CTXT_P0001S000005071member_S000005071member">&lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:12.0pt; font-family:"Times New Roman","serif"&apos;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:12.0pt;font-family:"Times New Roman","serif"&apos;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" align="center" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt; text-align:center;line-height:normal;text-autospace:none"&gt;&lt;b&gt;&lt;font style=&apos;font-size:10.0pt;font-family:"Times New Roman","serif"&apos;&gt;Please retain this Supplement with your Prospectus.&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;  &lt;p class="MsoNormal" align="center" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt; text-align:center;line-height:normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:10.0pt;font-family:"Times New Roman","serif"&apos;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" align="center" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt; text-align:center;line-height:normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:10.0pt;font-family:"Times New Roman","serif"&apos;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;margin-bottom:10.0pt;line-height:115%;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;"&gt;&amp;nbsp;&lt;/p&gt;</ck0001027596:SupplementClosingTextBlock>
  <dei:TradingSymbol contextRef="S000005071member_C000013857member">TEBRX</dei:TradingSymbol>
  <rr:MaximumSalesChargeImposedOnPurchasesOverOfferingPrice contextRef="S000005071member_C000013857member" unitRef="Ratio" decimals="4">0.0000</rr:MaximumSalesChargeImposedOnPurchasesOverOfferingPrice>
  <rr:MaximumDeferredSalesChargeOverOfferingPrice contextRef="S000005071member_C000013857member" unitRef="Ratio" decimals="4">0.0000</rr:MaximumDeferredSalesChargeOverOfferingPrice>
  <rr:RedemptionFeeOverRedemption contextRef="S000005071member_C000013857member" unitRef="Ratio" decimals="4">0.0000</rr:RedemptionFeeOverRedemption>
  <rr:ShareholderFeesTableTextBlock contextRef="CTXT_P0001S000005071member_S000005071member">&lt;div&gt; &amp;lt;div style="display:none;" &amp;gt;~ http://www.tebergfund.com/20121219/role/ShareholderFeesData_P0001-S000005071Member row primary compact * row dei_LegalEntityAxis compact ck0001027596_S000005071Member column rr_ProspectusShareClassAxis compact * column dei_LegalEntityAxis compact ck0001027596_S000005071Member ~&amp;lt;/div&amp;gt; &lt;/div&gt;</rr:ShareholderFeesTableTextBlock>
  <rr:ManagementFeesOverAssets contextRef="S000005071member_C000013857member" unitRef="Ratio" decimals="4">0.0150</rr:ManagementFeesOverAssets>
  <rr:DistributionAndService12b1FeesOverAssets contextRef="S000005071member_C000013857member" id="id_footnote_1000" unitRef="Ratio" decimals="4">0.0000</rr:DistributionAndService12b1FeesOverAssets>
  <rr:Component1OtherExpensesOverAssets contextRef="S000005071member_C000013857member" id="id_footnote_1001" unitRef="Ratio" decimals="4">0.0055</rr:Component1OtherExpensesOverAssets>
  <rr:OtherExpensesOverAssets contextRef="S000005071member_C000013857member" unitRef="Ratio" decimals="4">0.0205</rr:OtherExpensesOverAssets>
  <rr:AcquiredFundFeesAndExpensesOverAssets contextRef="S000005071member_C000013857member" unitRef="Ratio" decimals="4">0.0067</rr:AcquiredFundFeesAndExpensesOverAssets>
  <rr:ExpensesOverAssets contextRef="S000005071member_C000013857member" id="id_footnote_1002" unitRef="Ratio" decimals="4">0.0272</rr:ExpensesOverAssets>
  <rr:FeeWaiverOrReimbursementOverAssets contextRef="S000005071member_C000013857member" id="id_footnote_1003" unitRef="Ratio" decimals="4">-0.0034</rr:FeeWaiverOrReimbursementOverAssets>
  <rr:NetExpensesOverAssets contextRef="S000005071member_C000013857member" unitRef="Ratio" decimals="4">0.0238</rr:NetExpensesOverAssets>
  <rr:AnnualFundOperatingExpensesTableTextBlock contextRef="CTXT_P0001S000005071member_S000005071member">&lt;div&gt; &amp;lt;div style="display:none;" &amp;gt;~ http://www.tebergfund.com/20121219/role/OperatingExpensesData_P0001-S000005071Member row primary compact * row dei_LegalEntityAxis compact ck0001027596_S000005071Member column rr_ProspectusShareClassAxis compact * column dei_LegalEntityAxis compact ck0001027596_S000005071Member ~&amp;lt;/div&amp;gt; &lt;/div&gt;</rr:AnnualFundOperatingExpensesTableTextBlock>
  <rr:ExpenseExampleYear01 contextRef="S000005071member_C000013857member" unitRef="USD" decimals="0">241</rr:ExpenseExampleYear01>
  <rr:ExpenseExampleYear03 contextRef="S000005071member_C000013857member" unitRef="USD" decimals="0">812</rr:ExpenseExampleYear03>
  <rr:ExpenseExampleYear05 contextRef="S000005071member_C000013857member" unitRef="USD" decimals="0">1410</rr:ExpenseExampleYear05>
  <rr:ExpenseExampleYear10 contextRef="S000005071member_C000013857member" unitRef="USD" decimals="0">3026</rr:ExpenseExampleYear10>
  <rr:ExpenseExampleWithRedemptionTableTextBlock contextRef="CTXT_P0001S000005071member_S000005071member">&lt;div&gt; &amp;lt;div style="display:none;" &amp;gt;~ http://www.tebergfund.com/20121219/role/ExpenseExample_P0001-S000005071Member row primary compact * row dei_LegalEntityAxis compact ck0001027596_S000005071Member column rr_ProspectusShareClassAxis compact * column dei_LegalEntityAxis compact ck0001027596_S000005071Member ~&amp;lt;/div&amp;gt; &lt;/div&gt;</rr:ExpenseExampleWithRedemptionTableTextBlock>
  <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:footnote xlink:type="resource" xlink:label="footnote_1000" xlink:role="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">While the Fund has adopted a Rule 12b-1 Distribution Plan which authorizes the payment of up to 0.25% of the Fund&#8217;s average daily net assets for distribution and servicing activities, the Fund has determined not to pay any Rule 12b-1 fees through at least July 28, 2014.</link:footnote>
    <link:loc xlink:type="locator" xlink:href="#id_footnote_1000" xlink:label="DistributionAndService12b1FeesOverAssets_1001" />
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="DistributionAndService12b1FeesOverAssets_1001" xlink:to="footnote_1000" order="1.0" />
    <link:footnote xlink:type="resource" xlink:label="footnote_1001" xlink:role="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Other Expenses have been restated to reflect current fees as if they had been in effect during the previous fiscal year.</link:footnote>
    <link:loc xlink:type="locator" xlink:href="#id_footnote_1001" xlink:label="Component1OtherExpensesOverAssets_1002" />
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Component1OtherExpensesOverAssets_1002" xlink:to="footnote_1001" order="1.0" />
    <link:footnote xlink:type="resource" xlink:label="footnote_1002" xlink:role="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">The Total Annual Fund Operating Expenses for the Fund do not correlate to the Ratio of Expenses to Average Net Assets Before Expense Waiver provided in the Financial Highlights section of the statutory prospectus, which reflects the current operating expenses of the Fund and does not include Acquired Fund Fees and Expenses (&#8220;AFFE&#8221;).</link:footnote>
    <link:loc xlink:type="locator" xlink:href="#id_footnote_1002" xlink:label="ExpensesOverAssets_1003" />
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="ExpensesOverAssets_1003" xlink:to="footnote_1002" order="1.0" />
    <link:footnote xlink:type="resource" xlink:label="footnote_1003" xlink:role="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">First Associated Investment Advisors, Inc. (the &#8220;Advisor&#8221;) has contractually agreed to waive all or a portion of its management fees and pay expenses of the Fund to ensure that Net Annual Fund Operating Expenses (excluding AFFE, interest, taxes and extraordinary expenses) do not exceed 1.75% of the Fund&#8217;s average daily net assets (the &#8220;Expense Cap&#8221;).  The Expense Cap will remain in effect through at least July 28, 2014, and may be terminated only by the Trust&#8217;s Board of Trustees.  The Advisor may request recoupment of previously waived fees and paid expenses from the Fund for three years from the date they were waived or paid, subject to the Expense Cap.  Additionally, the Advisor has contractually agreed to reduce its management fee in the amount of any Rule 12b-1 fees received from transactions involving the Fund.  The Advisor will pay to the Fund the amount of any such Rule 12b-1 fees and for the fiscal year ended March 31, 2012, this amounted to 0.04%.  This management fee reduction will remain in effect at least through July 28, 2022, and may be terminated only with the consent of the Fund&#8217;s Board of Trustees.</link:footnote>
    <link:loc xlink:type="locator" xlink:href="#id_footnote_1003" xlink:label="FeeWaiverOrReimbursementOverAssets_1004" />
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="FeeWaiverOrReimbursementOverAssets_1004" xlink:to="footnote_1003" order="1.0" />
  </link:footnoteLink>
</xbrl>
